4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990) operates in the Biotechnology industry and is headquartered in Chengdu, China with about 2,300 employees. Its market capitalization is roughly HK$114 billion. In the fiscal year ended 2025-12-31, 6990 reported CNY 2.1B in revenue and (CNY 382M) in net income.
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, metabolism, and other therapeutic areas in the People's Republic of China and internationally.
Interactive charts & full statements → Open the 6990 valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | CNY 2.1B | CNY 1.9B | CNY 1.5B | CNY 804M | — |
| Gross Profit | CNY 1.5B | CNY 1.3B | CNY 759M | CNY 527M | — |
| Operating Income (EBIT) | (CNY 466M) | (CNY 211M) | (CNY 453M) | (CNY 394M) | — |
| Net Income | (CNY 382M) | (CNY 267M) | (CNY 574M) | (CNY 616M) | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | CNY 6.0B | CNY 4.3B | CNY 3.5B | CNY 993M | — |
| Total Liabilities | CNY 1.1B | CNY 959M | CNY 1.2B | CNY 4.2B | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 6990 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms